November 1, 2024
Retinal Detachment Articles
October 18, 2024
Scleral Buckling: Let There Be Light
By Jim Gallagher, senior managing editor
October 1, 2024
Ocular Side Effects of Systemic Chemotherapy Agents
By Kapil Mishra, MD, Rolando Sceptre Ganasi, BS
October 1, 2024
Ocular Side Effects of Systemic Chemotherapy Agents
By Kapil Mishra, MD, Rolando Sceptre Ganasi, BS
July 1, 2024
A Roundtable on Complications in Retinal Surgery
By Christina Y. Weng, MD, MBA, Lejla Vajzovic, MD, FASRS, Yoshihiro Yonekawa, MD, et al.
November 1, 2023
Clinical Pearls for Pediatric Retinal Detachment
By Seyyedehfatemeh Ghalibafan, MD, Louis Z. Cai, MD, Audina M. Berrocal, MD, et al.
November 1, 2023
Vitreoretinal Adverse Effects Associated With Oxymetazoline Drops for Blepharoptosis
By Jessica L. Barest, MD, Alan R. Dayan, MD
October 1, 2023
SUBSPECIALTY NEWS: Biosimilar FDA application hits roadblock, Apellis provides guidance on Syfovre use, and more.
By Rochelle Nataloni, contributing writer
July 1, 2023
Prevalence and Management of Retinal Detachment in High Myopia
By Cassie A. Ludwig, MD, MS, Darius M. Moshfeghi, MD
June 1, 2023
NEW PRODUCT APPLICATIONS: Improving Safety During Retinal Detachment Surgeries
By Karen Appold, contributing writer
October 1, 2022
SUBSPECIALTY NEWS: FDA approves Cimerli, GATHER2 GA trial meets primary endpoint, and more.
By Rochelle Nataloni, contributing writer
July 1, 2022
Bilateral Simultaneous Rhegmatogenous Retinal Detachments
By Tedi Begaj, MD, Drew Scoles, MD, PhD, Sandeep Randhawa, MD
July 1, 2022
Vitreoretinal Views on Vuity
By Suzanne Michalak, MD, Prithvi Mruthyunjaya, MD, MHS, Ehsan Rahimy, MD
January 1, 2022
Low-cost Peripheral Vitrectomy Without Surgical Assistance
By Wilson Wong, MD, FRCOphth, Yiran Tan MBBS, MMed, David Sia MBChB, FRANZCO, et al.